JC
Jean Chalopin
Chairman at Theravectys
View Jean's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
Chairman
Present
Company Details
11-50 Employees
Based in Paris and in the USA, TheraVectys is an immunotherapy company spun off from the Institut Pasteur created in 2005 by Dr. Pierre Charneau. TheraVectys is pioneering the application of novel lentiviral vector technology to address most of unmet and critical medical needs. By creating the only Joint-Laboratory between a private company and the Institut Pasteur in Paris, TheraVectys develops an extensive pipeline of vaccine candidates to drive the widespread treatment and prevention of cancer and infectious diseases. Leveraging our proprietary technology platform, and the extensive virology expertise of the Institut Pasteur, TheraVectys provides a robust and highly effective transfection mechanism to elicit a potent and targeted immune response previously unseen.
Year Founded
2005
Social Media
LinkedinTwitter
Industry
Biotechnology Research, Biotechnology research and development, Research and testing, IT, Internet, R&D
HQ Location
28, Rue du Docteur Roux Paris, Île-de-France 75015, FR
Keywords
BiotechnologyOncologyTherapeutic vaccinesInfectious DiseasesProphylactic vaccinesImmunotherapyTropical Diseasesand Lentiviral vectors
Discover More About Cleveland Clinic

Find verified contacts of Jean Chalopin in seconds from 700M people profiles. Start now!

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.